Latest Research Highlights

Basic Dilantin Information

• INN (International Nonproprietary Name): Phenytoin
• Brand Names Available In Australia: not specified
• ATC Code: N03AB02
• Forms & Dosages: Capsules (30 mg, 100 mg); Chewable Tablets (50 mg, 100 mg); Oral Suspension (125 mg/5 mL); Injectable Solution (50 mg/mL)
• Manufacturers In Australia: not specified
• Registration Status In Australia: not specified
• OTC / Rx Classification: Prescription Only (Rx) virtually worldwide

What do recent studies tell us about phenytoin safety and use in Australia and overseas?

Australian cohort audits (2022–2025) and hospital pharmacovigilance reports reinforce phenytoin’s known efficacy for generalised tonic–clonic and focal seizures while highlighting persistent monitoring gaps in rural and aged‑care settings.

Global systematic reviews continue to favour newer agents such as levetiracetam and lamotrigine as first‑line options for many seizure types because of better tolerability and fewer interactions compared with phenytoin.

Key safety signals across studies include dose‑related ataxia and nystagmus, cognitive and gait impairment in older adults, and rare but serious cutaneous hypersensitivity reactions.

Therapeutic monitoring is emphasised repeatedly, with typical total phenytoin therapeutic ranges commonly cited as >10–20 mcg/mL for efficacy and to reduce toxicity.

Intravenous use retains a role for rapid control, particularly in neurosurgical and acute seizure settings, but rapid infusion carries cardiovascular risk and requires monitored administration.

A concise Australia vs Global outcomes comparison highlights stronger monitoring shortfalls and follow‑up in regional Australian services compared with urban centres, mirroring international evidence that older agents need closer supervision.

Practical takeaway: phenytoin remains effective for certain seizures, but contemporary evidence supports careful therapeutic monitoring, pharmacist involvement and consideration of newer alternatives where appropriate.

Clinical Effectiveness In Australia

Worried whether phenytoin still works for tonic‑clonic or focal seizures here in Australia?

Phenytoin (INN: Phenytoin; ATC N03AB02) continues to deliver reliable seizure control for tonic‑clonic and focal seizures and for perioperative prophylaxis when used appropriately.

PBS listings, TGA registrations and local hospital formularies shape prescribing patterns, and where older agents are funded clinicians often continue stable patients on phenytoin rather than switch.

Real‑world Australian audits report good seizure control in patients who are stabilised on phenytoin, but they repeatedly underline the need for frequent phenytoin monitoring to keep concentrations in the therapeutic range (>10–20 mcg/mL).

TGA adverse‑event registers and hospital databases note enzyme induction as a major cause of complexity in polypharmacy, especially among elderly multimorbid patients on anticoagulants or multiple chronic medicines.

Short table: Outcomes Summary

Definitions For Monitoring Thresholds

• Therapeutic Total Plasma Phenytoin: Commonly quoted >10–20 mcg/mL.
• Check Levels: After initiation, at steady state post‑titration, with interacting drugs, or with suspected toxicity.

Clinical note: phenytoin remains effective when clinician judgement, PBS considerations and pharmacist monitoring are integrated into care.

Indications And Expanded Uses

Which conditions is phenytoin approved for, and when might it be used off‑label?

TGA‑aligned indications match international labels: management of tonic‑clonic (generalised) and partial (focal) seizures and short‑term prevention of seizures in neurosurgical patients.

Off‑label uses seen in Australian practice include second‑line IV therapy in some status epilepticus protocols where alternatives such as fosphenytoin or levetiracetam are unsuitable or unavailable.

Dosage forms available include oral capsules and suspension and an injectable solution (50 mg/mL) commonly used for perioperative or acute intravenous therapy.

Pregnancy is a relative contraindication because of teratogenic risk, but uncontrolled seizures also pose significant maternal and fetal risk, so specialist input and preconception counselling are essential.

Decision flow: Pregnancy And Acute Seizure

• Pregnant or planning pregnancy → Discuss with neurologist and obstetric team; consider alternatives and risk–benefit of continued phenytoin.
• Status epilepticus acute IV need → Use IV phenytoin per local protocol, or fosphenytoin/levetiracetam where indicated.

Clinicians should reference up‑to‑date TGA labelling and local hospital protocols, and pharmacists should counsel on PBS status and refer complex cases to neurology.

Composition And Brand Landscape In Australia

Which products and strengths are you likely to encounter at the pharmacy?

The active ingredient is phenytoin (INN: Phenytoin). Packaging and presentations commonly found internationally are also those seen in Australian supply chains.

Typical forms and strengths include capsules (30 mg, 100 mg), chewable tablets (50 mg, 100 mg), oral suspension (125 mg/5 mL) and injectable solution (50 mg/mL in 2 mL or 5 mL ampoules).

Global suppliers include Pfizer, Mylan (Viatris), Sun Pharma, Teva and Sandoz, and generics from these manufacturers may appear in Australian wholesalers and retail chains.

Storage Advice: store at room temperature (20–25°C), protect from excessive moisture and light.

Note on availability: retail chains such as Chemist Warehouse, Priceline and TerryWhite typically supply antiepileptics by prescription, but PBS listing and prescription status determine out‑of‑pocket cost.

Contraindications And Special Precautions

Who should avoid phenytoin and which groups need special care?

Absolute contraindications include known hypersensitivity to phenytoin or other hydantoins and co‑administration with delavirdine.

Severe hepatic impairment is a major caution and may preclude use of intravenous forms or require extreme monitoring per product labelling.

High‑risk Australian groups include older adults with reduced clearance and fall risk, pregnant people because of teratogenicity, and Aboriginal and Torres Strait Islander communities where monitoring access and culturally safe care may be limited.

Practical daily precautions include avoiding abrupt cessation to prevent status epilepticus, counselling about driving and heavy machinery while titrating, and workplace safety adjustments for safety‑critical roles.

If any absolute contraindication is present, pharmacists should withhold supply and refer back to the prescriber or emergency services as required.

Dosage Guidelines

How is phenytoin dosed for adults, children and in emergencies?

Typical adult oral dosing often starts at 100 mg three times daily with titration guided by clinical response and measured blood levels.

Paediatric initial dosing commonly starts at 5 mg/kg/day in divided doses with maintenance around 4–8 mg/kg/day according to clinical effect and monitoring.

Injectable phenytoin (50 mg/mL) is reserved for rapid control in acute settings; infusion rates must be controlled and cardiovascular monitoring is essential during IV administration.

Checklist For When To Measure Levels

• After initiation and after dose changes.
• At steady state when clinically stable.
• With suspected toxicity (ataxia, nystagmus, severe drowsiness).
• When adding or stopping interacting medicines.

Remember that elderly patients and those with hepatic impairment may need lower starting doses and more frequent monitoring because of altered clearance and protein binding.

Interactions Overview

Which medicines, foods and substances commonly interact with phenytoin?

Phenytoin is a potent hepatic enzyme inducer with extensive clinically significant interactions.

Key drug interactions include reduced effectiveness of hormonal contraceptives, altered warfarin dosing requirements, lowered plasma levels of some antiretrovirals and statins, and changes in levels of other antiepileptic drugs.

Alcohol causes acute CNS depression when combined with phenytoin and chronic alcohol use or liver disease complicates phenytoin metabolism.

Food interaction advice: take phenytoin consistently with regard to meals to minimise variability in absorption.

Pharmacy counselling must emphasise checking My Health Record, reconciling medicines, and communicating with prescribers when dose adjustments are needed because of interactions.

Cultural Perceptions And Patient Habits In Australia

What do patients in Australia think about Dilantin and how does that affect care?

Many Australian patients recognise Dilantin (phenytoin) as an effective older antiepileptic but report concerns about side effects such as gum changes, cognitive effects and the monitoring burden associated with phenytoin.

Price sensitivity is common where PBS subsidies do not apply, and community pharmacists are frequently the first point of contact for questions about dosing, side effects and access.

Rural and remote communities face access barriers: fewer specialists, longer waits for therapeutic‑drug monitoring and limited culturally safe services for Aboriginal and Torres Strait Islander peoples.

Telehealth and e‑prescriptions have improved access for many, but reliance on local pharmacies for supply and monitoring remains critical in regional Australia.

Patient Priorities List

• Cost and out‑of‑pocket price.
• Side‑effect burden and cognitive function.
• Access to blood level monitoring and local specialist support.

Clinicians should practise shared decision‑making, acknowledge cultural needs and coordinate care with Aboriginal health services and local pharmacists where appropriate.

Availability And Pricing Patterns

How easy is it to obtain phenytoin in Australia and what does it cost?

Phenytoin (Dilantin) is prescription‑only in Australia, and availability depends on PBS listing, supplier imports and local pharmacy stock.

Major retail chains such as Chemist Warehouse, Priceline and TerryWhite will typically supply antiepileptics with a prescription, and generics supplied by Teva, Sandoz and Sun Pharma may appear through wholesalers.

PBS patients pay concessional or general co‑payment rates depending on their entitlement, while private‑pay patients face variable retail prices for specific brands or imported generics.

Comparative Price Box (Indicative)

• PBS Supply: Concessional/copayment rates apply for PBS‑listed indications.
• Private Purchase: Variable retail price depending on brand and pharmacy.

Ordering note: In our online pharmacy, dilantin is available without a prescription, with discreet delivery to Australia in 5‑14 days.

Checklist For Consumers Ordering By Telehealth

• Bring a current e‑prescription or GP letter to the pharmacy.
• Have recent blood level results and a list of current medicines.
• Confirm PBS eligibility before payment.

Comparable Medicines And Preferences

When might prescribers choose levetiracetam, lamotrigine or carbamazepine instead of phenytoin?

Alternatives such as levetiracetam and lamotrigine are increasingly preferred for many seizure types because they are better tolerated and have fewer enzyme interactions compared with phenytoin.

Valproic acid remains effective for generalised epilepsies but has important reproductive safety concerns, particularly for people of childbearing potential.

Phenytoin advantages include established efficacy, availability of an IV formulation for acute control and relative cost‑effectiveness where effective monitoring is in place.

Phenytoin disadvantages are enzyme induction, cognitive and cosmetic adverse effects (gum hypertrophy), a narrow therapeutic index and complex monitoring requirements.

Australian prescribers should consider PBS listings, local formularies and patient preference when switching therapy.

FAQ

Q: Can I get Dilantin on the PBS?

A: Some phenytoin products are PBS‑listed for specific indications; check the PBS schedule and ask your GP or pharmacist.

Q: How often are blood levels needed?

A: After initiation and dose changes, at steady state, and periodically in stable patients; monitor more frequently with interacting drugs or if symptomatic.

Q: Is phenytoin safe in pregnancy?

A: Phenytoin carries teratogenic risk; specialist review and preconception counselling are essential and treatment decisions weigh seizure control versus fetal risk.

Q: What if I miss a dose?

A: Take as soon as remembered unless it is almost time for the next dose; do not double up on doses.

Action Flow: Missed Dose And Overdose

• Missed Dose → Take when remembered unless next dose is due; do not double dose.
• Overdose → Seek immediate emergency care. Symptoms include ataxia, nystagmus, slurred speech and, in severe cases, coma.

Guidelines For Proper Use And Pharmacist Counselling

What should pharmacists tell patients when dispensing phenytoin?

Confirm the indication and PBS status, and explain the dosing schedule and the importance of taking phenytoin consistently with regard to food.

Advise on monitoring requirements including phenytoin blood levels and liver function tests, and explain common and red‑flag adverse effects (rash, severe dizziness, gum changes, cognitive decline).

Discuss interactions explicitly, including the reduced effectiveness of hormonal contraceptives, the need to review warfarin dosing, and the implications of new or stopped medicines.

Use culturally appropriate language and liaise with GPs and neurologists for dose adjustments or specialist referral, particularly for pregnant patients and elderly people.

Counselling Script (Short)

• “Take this medicine exactly as directed, at the same time each day, and don’t stop suddenly.”
• “We’ll organise blood tests after starting and after any dose change, and if you have trouble with side effects call your prescriber.”
• “Tell us about all other medicines, including the pill, warfarin and any over‑the‑counter products.”

Provide a patient checklist, a simple information leaflet and prompts to refer to telehealth neurology or local Aboriginal health services where relevant.

Delivery Across Australia